These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 27924175)
1. Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio. Singh G J Clin Med Res; 2017 Jan; 9(1):46-57. PubMed ID: 27924175 [TBL] [Abstract][Full Text] [Related]
2. Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies: High False-Positive Rate. Singh G Am J Clin Pathol; 2016 Aug; 146(2):207-14. PubMed ID: 27473738 [TBL] [Abstract][Full Text] [Related]
3. Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies. Lee WS; Singh G J Clin Med Res; 2018 Jul; 10(7):562-569. PubMed ID: 29904440 [TBL] [Abstract][Full Text] [Related]
4. Quantification of Free Immunoglobulin Light Chains in Urine. Singh G; Cotter T; Ye Mon M; Xu H; Bollag RJ J Appl Lab Med; 2023 Nov; 8(6):1101-1114. PubMed ID: 37725944 [TBL] [Abstract][Full Text] [Related]
5. Serum Free Light Chain Assay in Monoclonal Gammopathic Manifestations. Lee WS; Singh G Lab Med; 2019 Oct; 50(4):381-389. PubMed ID: 30957173 [TBL] [Abstract][Full Text] [Related]
6. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays. Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636 [TBL] [Abstract][Full Text] [Related]
7. Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies. Singh G J Appl Lab Med; 2020 Nov; 5(6):1358-1371. PubMed ID: 33150391 [TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850 [TBL] [Abstract][Full Text] [Related]
9. Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas. Singh G Lab Med; 2019 Apr; 50(2):189-193. PubMed ID: 30423164 [TBL] [Abstract][Full Text] [Related]
10. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies? Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305 [TBL] [Abstract][Full Text] [Related]
11. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis. Jaskowski TD; Litwin CM; Hill HR Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338 [TBL] [Abstract][Full Text] [Related]
12. Urine Protein Immunofixation Electrophoresis: Free Light Chain Urine Immunofixation Electrophoresis Is More Sensitive than Conventional Assays for Detecting Monoclonal Light Chains and Could Serve as a Marker of Minimal Residual Disease. Singh G; Arinze N; Manthei DM; Plapp FV; Bollag RJ Lab Med; 2023 Sep; 54(5):527-533. PubMed ID: 36857478 [TBL] [Abstract][Full Text] [Related]
13. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies. Wood PB; McElroy YG; Stone MJ Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664 [TBL] [Abstract][Full Text] [Related]
14. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920 [TBL] [Abstract][Full Text] [Related]
15. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma. Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439 [TBL] [Abstract][Full Text] [Related]
16. Oligoclonal Pattern/Abnormal Protein Bands in Post-Treatment Plasma Cell Myeloma Patients: Implications for Protein Electrophoresis and Serum Free Light Chain Assay Results. Singh G J Clin Med Res; 2017 Aug; 9(8):671-679. PubMed ID: 28725315 [TBL] [Abstract][Full Text] [Related]
17. POEMS Syndrome with IgG-λ/IgA-κ Biclonal Gammopathy and Abnormal Serum Free Light Chain Ratio: a Case Report. Ham JY; Suh JS; Lee WK; Song KE Ann Clin Lab Sci; 2015; 45(6):702-6. PubMed ID: 26663802 [TBL] [Abstract][Full Text] [Related]
18. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum. Smith J; Raines G; Schneider HG Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572 [TBL] [Abstract][Full Text] [Related]
20. A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female. Fager Ferrari M; Lemonakis K; Förnvik Jonsson M Scand J Clin Lab Invest; 2021 Sep; 81(5):385-388. PubMed ID: 34097568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]